A serial MRI study following optic nerve mean area in acute optic neuritis

Brain

Volumn 127, Issue 11, 2004, Pages 2498-2505

  Hickman, Simon J ^a,c   Toosy, Ahmed T ^a,c   Jones, Stephen J ^b   Altmann, Daniel R ^a,d   Miszkiel, Katharine A ^b   MacManus, David G ^a   Barker, Gareth J ^a,e   Plant, Gordon T ^c   Thompson, Alan J ^a   Miller, David H ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^c MOORFIELDS EYE HOSPITAL   (United Kingdom)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^e KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Atrophy; Disability; MRI; Multiple sclerosis; Optic neuritis

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; DEMYELINATING DISEASE; EVOKED VISUAL RESPONSE; FEMALE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE; OPTIC NERVE DISEASE; PRIORITY JOURNAL; VISUAL ACUITY; VISUAL DISORDER; VISUAL IMPAIRMENT;

ACUTE DISEASE; ADULT; EVOKED POTENTIALS, VISUAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OPTIC NERVE; OPTIC NEURITIS; PROSPECTIVE STUDIES; REFERENCE VALUES; VISION DISORDERS; VISUAL ACUITY; VISUAL FIELDS;

EID: 8144229803     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/awh284     Document Type: Article

References (39)

1. Barker GJ. Technical issues for the study of the optic nerve with MRI. J Neurol Sci 2000; 172 Suppl 1: S13-6.
2. Beck RW. Optic neuritis. In: Miller NR, Newman NJ, editors. Walsh and Hoyt's clinical neuro-ophthalmology. 5th edn. Baltimore: Williams and Wilkins; 1998, p. 599-647.
3. Behan CMH, Hickman SJ, Scolding NJ, Miller DH, Compston DAS. Identification of the clinically symptomatic lesion in multiple sclerosis-implications for remyelination therapy. Rev Neurol (Paris) 2000; 156 Suppl 3: S28.
4. Bland JM, Altman DG. Measurement error and correlation coefficients. Br Med J 1996; 313: 41-2.
5. Bruck W, Bitsch A, Kolenda H, Bruck Y, Stiefel M, Lassmann H. Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology. Ann Neurol 1997; 42: 783-93.
6. Brusa A, Jones SJ, Plant GT. Long-term remyelination after optic neuritis: a 2-year visual evoked potential and psychophysical serial study. Brain 2001; 124: 468-79.
7. Brasaferri F, Candelise L. Steroids for multiple sclerosis and optic neuritis: a meta-analysis of randomized controlled clinical trials. J Neurol 2000; 247: 435-42.
8. Carpenter J, Bithell J. Bootstrap confidence intervals: when, which, what? A practical guide for medical statisticians. Stat Med 2000; 19: 1141-64.
9. Cornblath WT, Quint DJ. MRI of optic nerve enlargement in optic neuritis. Neurology 1997; 48: 821-5.
10. Ebers GC. Optic neuritis and multiple sclerosis. Arch Neurol 1985; 42: 702-4.
11. Ferguson B, Matyszak MK, Esiri MM, Perry VH. Axonal damage in acute multiple sclerosis lesions. Brain 1997; 120: 393-9.
12. Ferns FL 3rd, Kassoff A, Bresnick GH, Bailey I. New visual acuity charts for clinical research. Am J Ophthalmol 1982; 94: 91-6.
13. Frisén L, Quigley HA. Visual acuity in optic atrophy: a quantitative clinicopathological analysis. Graefes Arch Clin Exp Ophthalmol 1984; 222: 71-4.
14. Gass A, Moseley IF, Barker GJ, Jones S, MacManus D, McDonald WI, et al. Lesion discrimination in optic neuritis using high-resolution fat-suppressed fast spin-echo MRI. Neuroradiology 1996; 38: 317-21.
15. Goldstein H. Multilevel statistical models. 2nd edn. London: Arnold; 1995.
16. Halliday AM, McDonald WI, Mushin J. Delayed visual evoked response in optic neuritis. Lancet 1972; 1: 982-5.
17. Hickman SJ, Brex PA, Brierley CMH, Silver NC, Barker GJ, Scolding NJ, et al. Detection of optic nerve atrophy following a single episode of unilateral optic neuritis by MRI using a fat-saturated short-echo fast FLAIR sequence. Neuroradiology 2001; 43: 123-8.
18. Hickman SJ, Brierley CMH, Brex PA, MacManus DG, Scolding NJ, Compston DAS, et al. Continuing optic nerve atrophy following optic neuritis: a serial MRI study. Mult Scler 2002; 8: 339-42.
19. Hickman SJ, Kapoor R, Jones SJ, Altmann DR, Plant GT, Miller DH. Corticosteroids do not prevent optic nerve atrophy following optic neuritis. J Neurol Neurosurg Psychiatry 2003; 74: 1139-41.
20. Hickman SJ, Toosy AT, Jones SJ, Altmann DR, Miszkiel KA, MacManus DG, et al. Serial magnetization transfer imaging in acute optic neuritis. Brain 2004; 127: 692-700.
21. Inglese M, Ghezzi A, Bianchi S, Gerevini S, Sormani MP, Martinelli V, et al. Irreversible disability and tissue loss in multiple sclerosis: a conventional and magnetization transfer magnetic resonance imaging study of the optic nerves. Arch Neurol 2002; 59: 250-5.
22. Kapoor R, Miller DH, Jones SJ, Plant GT, Brusa A, Gass A, et al. Effects of intravenous methylprednisolone on outcome in MRI-based prognostic subgroups in acute optic neuritis. Neurology 1998; 50: 230-7.
23. Katz D, Taubenberger JK, Cannella B, McFarlin DE, Raine CS, McFarland HF. Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis. Ann Neurol 1993; 34: 661-9.
24. Kupersmith MJ, Alban T, Zeiffer B, Lefton D. Contrast-enhanced MRI in acute optic neuritis: relationship to visual performance. Brain 2002; 125: 812-22.
25. Lublin FD, Baier M, Cutter G. Effect of relapses on development of residual deficit in multiple sclerosis. Neurology 2003; 61: 1528-32.
26. McGavern DB, Murray PD, Rivera-Quinones C, Schmelzer JD, Low PA, Rodriguez M. Axonal loss results in spinal cord atrophy, electrophysiological abnormalities and neurological deficits following demyelination in a chronic inflammatory model of multiple sclerosis. Brain 2000; 123: 519-31.
27. Miller DH, Grossman RI, Reingold SC, McFarland HF. The role of magnetic resonance techniques in understanding and managing multiple sclerosis. Brain 1998; 121: 3-24.
28. Miller DH, Barkhof F, Frank JA, Parker GJ, Thompson AJ. Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. Brain 2002; 125: 1676-95.
29. Optic Neuritis Study Group. The clinical profile of optic neuritis. Experience of the Optic Neuritis Treatment Trial. Arch Ophthalmol 1991; 109: 1673-8.
30. Plummer DL. DispImage: a display and analysis tool for medical images. Riv Neuroradiol 1992; 5: 489-95.
31. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227-31.
32. Scolding N, Franklin R. Axon loss in multiple sclerosis. Lancet 1998; 352: 340-1.
33. Smith KJ, McDonald WI. The pathophysiology of multiple sclerosis: the mechanisms underlying the production of symptoms and the natural history of the disease. Philos Trans R Soc Lond B Biol Sci 1999; 354: 1649-73.
34. Snedecor GW, Cochran WG. Statistical methods. 8th edn. Ames (IA): Iowa State University Press; 1989.
35. Thorpe JW, Kidd D, Moseley IF, Kendall BE, Thompson AJ, MacManus DG, et al. Serial gadolinium-enhanced MRI of the brain and spinal cord in early relapsing-remitting multiple sclerosis. Neurology 1996; 46: 373-8.
36. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998; 338: 278-85.
37. Werring DJ, Bullmore ET, Toosy AT, Miller DH, Barker GJ, MacManus DG, et al. Recovery from optic neuritis is associated with a change in the distribution of cerebral response to visual stimulation: a functional magnetic resonance imaging study. J Neurol Neurosurg Psychiatry 2000; 68: 441-9.
38. Youl BD, Turano G, Miller DH, Towell AD, MacManus DG, Moore SG, et al. The pathophysiology of acute optic neuritis. An association of gadolinium leakage with clinical and electrophysiological deficits. Brain 1991; 114: 2437-50.
39. Youl BD, Turano G, Towell AD, Barrett G, MacManus DG, Moore SG, et al. Optic neuritis: swelling and atrophy. Electroencephalogr Clin Neurophysiol Suppl 1996; 46: 173-9.